查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024915

局部鎮痛藥市場規模、佔有率、趨勢和預測：按治療領域、劑型、類型、分銷管道和地區分類，2026-2034 年

Topical Pain Relief Market Size, Share, Trends and Forecast by Therapeutic Class, Formulation, Type, Distribution Channel, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2025年全球局部止痛藥市場規模為116億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以4.89%的複合年成長率成長，到2034年達到181億美元。目前，北美市場主導地位，預計2025年市佔率將超過35.0%。推動北美局部局部藥市場佔有率成長的因素包括：對非鴉片類鎮痛藥的需求不斷成長、人口老齡化加劇、消費者對非處方藥的偏好增強、產品配方不斷改進以及電子商務和零售藥店管道的拓展。

關節炎、背痛和肌肉骨骼疾病的日益普遍，推動了對標靶疼痛管理方案的需求，進而促進了外用鎮痛藥市場的發展。這些疾病在老年人和久坐人群中更為常見，凸顯了有效且易於獲得的治療方法的重要性。此外，許多人更傾向於使用外用藥物而非口服藥物，以降低全身性副作用的風險。外用製劑是治療慢性疼痛的首選，因為它們能夠提供局部緩解，並且被認為可以長期安全使用。此外，持續的創新正在推動先進產品的研發，例如速效凝膠、長效貼劑以及基於天然成分的產品。這些改進提升了使用者體驗和療效，從而提高了產品的使用率。此外，各公司正透過進行有針對性的行銷宣傳活動和產品廣告，提高消費者對產品認知度和接受度，並向使用者普及外用鎮痛藥的益處。

美國在局部止痛藥市場成長中扮演著至關重要的角色，這主要得益於不斷成長的老年人口，他們更容易患上關節疼痛、骨關節炎和其他肌肉骨骼疾病。此外，電子商務通路的普及也提升了消費者的購買便利性。數位平台提供豐富的產品選擇、詳盡的資訊和極具競爭力的價格，幫助使用者做出明智的購買決策。宅配的便利性和線上產品比較功能正在推動產品的普及，尤其是在精通技術的消費者群體中。製造商和經銷商正利用數位平台拓展客戶群，並提供線上專屬促銷、會員計畫和個人化行銷策略。使用者友善介面和安全支付方式的日益普及進一步促進了消費者向線上購物的轉變，使電子商務成為市場成長的關鍵因素。 2024 年 11 月，美國商務部人口普查局宣布，預計 2024 年第三季美國零售電子商務銷售額將達到 3,001 億美元，比 2024 年第二季成長 2.6%。

局部鎮痛藥市場趨勢：

關節炎和肌肉骨骼疾病的盛行率增加

局部鎮痛劑，如乳膏、凝膠和貼劑，因其與口服藥物相比全身副作用風險較低且能提供針對性鎮痛，而備受青睞。根據世界衛生組織（WHO）統計，全球約有17.1億人患有肌肉骨骼疾病，推動了對局部鎮痛解決方案的需求。對局部鎮痛劑市場的分析表明，這些療法對患有多種疾病且正在服用多種類風濕性關節炎的老年人尤其有益，因為它們可以降低藥物交互作用的風險。越來越多的人認可局部療法作為口服鎮痛劑的有效替代方案，這正在推動市場顯著擴張。骨關節炎和類風濕性關節炎等疾病患者通常能迅速緩解局部不適，進而改善身體機能和生活品質。吸收技術和緩釋製劑的改進進一步提升了使用者滿意度。此外，天然和有機產品的進步也滿足了人們對更安全、更永續治療方法的日益成長的需求。

藥物傳輸技術的不斷進步

藥物遞送技術的不斷進步是提高局部鎮痛產品療效的關鍵，也是局部鎮痛市場的主要發展趨勢。美國製藥業擁有超過130萬名員工，推動了微膠囊化、奈米製劑和經皮吸收貼片創新遞送機制的進步。這些技術能夠提高藥物經皮吸收率，實現控釋和活性成分（API）的精準標靶化，從而增強疼痛管理效果。透過減少全身暴露和最大程度地降低副作用，這些非侵入性技術滿足了使用者對更安全替代傳統口服藥物的需求。此外，藥物遞送系統的改進也使現有藥物得以增強，透過提高療效和患者依從性，使一些老牌活性成分煥發新生。各公司也正在研究整合多種技術的混合系統，例如使用微針封裝活性成分，進一步拓展了創新的可能性。

增加研發投入

根據局部鎮痛藥的市場調查報告，製藥公司不斷加大研發投入，推動了療效更佳、作用時間更長、副作用更少的先進配方的開發。這些努力包括探索具有鎮痛作用的新型活性成分和天然物質，以滿足消費者對有機和天然來源替代品日益成長的需求。全球鎮痛藥市場預計到2024年將達到563億美元，凸顯了疼痛緩解解決方案的巨大發展潛力。製藥公司正利用研發力量開發創新的局部鎮痛給藥系統，例如速效凝膠和長效貼片。此外，拓展不同效力和活性成分的產品線，旨在滿足從輕度到重度疼痛患者的廣泛需求。這些進步正在提升產品性能，並幫助企業在競爭激烈的市場中脫穎而出。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球局部止痛藥市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依治療區域分類

  • 非鴉片類藥物
  • 鴉片類藥物

第7章 市場區隔：依配方分類

  • 奶油
  • 凝膠
  • 噴
  • 修補
  • 其他

第8章 市場區隔：依類型

  • 處方止痛藥
  • 非處方止痛藥

第9章 市場區隔：依分銷通路分類

  • 藥局和藥局
  • 零售店
  • 網路商店

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Advacare Pharma
    • Exzell Pharma Inc.
    • Glaxosmithkline Plc
    • Johnson & Johnson
    • Novartis AG
    • Pfizer Inc.
    • Reckitt Benckiser Group Plc
    • Sanofi SA
    • Sun Pharmaceutical Industries Limited
    • Topical Biomedics Inc.
Product Code: SR112026A4441

The global topical pain relief market size was valued at USD 11.6 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 18.1 Billion by 2034, exhibiting a CAGR of 4.89% from 2026-2034. North America currently dominates the market, holding a market share of over 35.0% in 2025. The rising demand for non-opioid analgesics, expanding aging population, heightened consumer preference for OTC products, ongoing product innovations with enhanced formulations, and wider availability through e-commerce and retail pharmacies are some of the factors increasing the North America topical pain relief market share.

The rising cases of arthritis, back pain, and musculoskeletal disorders are fueling the need for targeted pain management solutions, which is increasing the topical pain relief market demand. These conditions are common among aging populations and individuals with sedentary lifestyles, emphasizing the need for effective and accessible treatments. Additionally, many individuals favor topical solutions over oral medications to reduce the risk of systemic side effects. Topical formulations offer localized relief and are considered safer for prolonged use, making them a preferred choice for managing chronic pain. Besides this, continuous innovation is leading to the development of advanced products, including fast-absorbing gels, long-lasting patches, and natural ingredient-based solutions. These enhancements improve user experience and efficacy, increasing adoption. Moreover, companies are adopting targeted marketing campaigns and product-specific advertisements to educate users about the benefits of topical pain relief, driving product awareness and acceptance.

The United States plays a crucial role in topical pain relief market growth, driven by the growing geriatric demographic that is more prone to conditions like joint pain, osteoarthritis, and other musculoskeletal disorders. Furthermore, the increasing number of e-commerce channels are enhancing accessibility and convenience for buyers. Digital platforms offer a diverse array of product choices, comprehensive details, and competitive pricing, allowing users to make well-informed buying decisions. The ease of home delivery and the option to compare products online lead to higher adoption rates, especially among tech-savvy people. Producers and sellers are utilizing digital platforms to broaden their audience, providing exclusive online promotions, memberships, and personalized marketing strategies. The increasing integration of user-friendly interfaces and secure payment options further encourages buyers to shift towards online purchases, making e-commerce a vital factor for the market growth. In November 2024, the Census Bureau of the Department of Commerce announced that the projected US retail e-commerce sales for the third quarter of 2024 reached $300.1 billion, indicating an increase of 2.6 percent compared to the second quarter of 2024.

TOPICAL PAIN RELIEF MARKET TRENDS:

Increasing prevalence of arthritis and musculoskeletal disorders

Topical pain relief options, including creams, gels, and patches, offer targeted pain alleviation with a lower risk of systemic side effects compared to oral medications, making them a preferred choice for many. According to the World Health Organization (WHO), around 1.71 billion people globally suffer from musculoskeletal disorders, driving the demand for localized pain management solutions. Topical pain relief market insights highlight that these treatments are particularly beneficial for seniors dealing with multiple health conditions and medications, reducing the risks of drug interactions. The growing endorsement of topical therapies as effective alternatives to oral pain relievers has significantly expanded the market. People experiencing conditions like osteoarthritis and rheumatoid arthritis often experience rapid relief from localized discomfort, improving their mobility and overall life quality. Improvements such as better absorption techniques and extended-release formulations further enhance user involvement. Additionally, the progress of natural and organic products addresses the increasing need for safer and more sustainable treatment options.

Continual advancements in drug delivery technologies

The ongoing progress in drug delivery technologies, which are crucial for improving the efficacy of topical pain relief items, is a significant topical pain relief market trend. The US pharmaceutical industry, which provides jobs for more than 1.3 million people, has led advancements in innovative delivery mechanisms like microencapsulation, nano-formulations, and transdermal patches. These technologies facilitate improved skin absorption, regulated release, and accurate targeting of active pharmaceutical ingredients (APIs), leading to enhanced pain management results. By decreasing systemic exposure and lowering side effects, these non-invasive techniques match the increasing user demand for safer options compared to conventional oral medications. Moreover, improvements in drug delivery systems allow for the reworking of current medications, revitalizing older APIs by boosting their effectiveness and patient adherence. Companies are also investigating hybrid systems that integrate various technologies, like microneedles with encapsulated APIs, which expands the potential for innovation even more.

Increased investment in research and development (R&D)

The topical pain relief market research report indicates that heightened research and development (R&D) investments from pharmaceutical firms are driving the development of advanced formulations with enhanced efficacy, longer action durations, and fewer side effects. These initiatives also include investigating novel active ingredients and natural substances with pain-relieving effects, responding to the increasing need for organic and natural alternatives. The worldwide analgesics market, estimated at USD 56.3 billion in 2024, underscores the vast potential for advancements in pain relief solutions. Pharmaceutical firms are utilizing R&D to create innovative drug delivery systems, like quick-absorbing gels and enduring patches, that offer focused relief. Additionally, initiatives aimed at expanding product ranges with different strengths and active components address a broad spectrum of user requirements, spanning from mild to intense pain relief. These advancements enhance product performance and assist companies in standing out in a fiercely competitive market.

TOPICAL PAIN RELIEF INDUSTRY SEGMENTATION:

Analysis by Therapeutic Class:

  • Non-Opioids
  • Opioids

Non-opioids constitute the biggest segment with a market share of 72.8% due to their safety, efficacy, and lower likelihood of dependency in comparison to opioids. These items generally include active components like NSAIDs, menthol, or capsaicin, which are well-known for their capacity to reduce pain and inflammation without causing systemic side effects. Non-opioid pain relief options are frequently suggested for ailments such as arthritis, sprains, and muscle pain, offering focused and short-term alleviation. The segment gains from the increasing inclination towards non-invasive and over-the-counter alternatives, enabling people to handle minor pain issues without requiring prescriptions. Regulatory backing and public health programs encouraging the adoption of safer alternatives to opioids additionally foster this segment's expansion. Advancements in non-opioid products, such as sophisticated patches and quick-absorbing gels, are improving their efficacy and user satisfaction.

Analysis by Formulation:

  • Cream
  • Gel
  • Spray
  • Patch
  • Others

Patches dominate the market because of their efficiency, ease of use, and consistent release of active substances. These items deliver localized pain relief by sticking directly to the impacted area, guaranteeing focused effectiveness. In contrast to creams or gels, patches provide a steady, regulated release of medication, minimizing the necessity for constant reapplication and improving patient adherence. Their subtle design and simple operation make them a favored option for people dealing with ongoing issues such as arthritis or back pain. Moreover, patches reduce the chance of mess or residue, providing a tidy and convenient option. Technological progress is fostering the creation of cutting-edge patch designs, featuring enhanced adhesion, flexibility, and suitability for various skin types. Numerous patches are now blended with a mix of active components, including lidocaine, menthol, or capsaicin, to boost effectiveness.

Analysis by Type:

  • Prescription Pain Relief
  • Over the Counter (OTC) Pain Relief

Over-the-counter (OTC) pain relief segment dominates the market with a market share of 61.4%. It addresses the demand for accessible and convenient solutions for minor pain conditions. These products, including creams, gels, and patches, are widely used for temporary relief from muscle aches, sprains, and mild arthritis. The ease of purchase without a prescription and the availability in pharmacies, supermarkets, and online platforms make OTC pain relief highly popular. Active ingredients such as menthol, capsaicin, and diclofenac are commonly included, ensuring quick and effective relief.

Analysis by Distribution Channel:

  • Pharmacy and Drug Stores
  • Retail Stores
  • Online Stores

Online stores lead the market with a market share of 56.0% due to their ease of use, extensive product selection, and attractive pricing. These platforms offer convenient access to a variety of products, enabling consumers to evaluate choices and make knowledgeable decisions from the ease of their residences. The rise in e-commerce adoption, fueled by greater internet access and smartphone usage, is further supporting the market growth. Numerous online merchants provide comprehensive product descriptions, customer reviews, and suggestions, boosting buyer confidence and streamlining the buying experience. Moreover, appealing discounts, subscription options, and rapid delivery services enhance their attractiveness. Producers are also leveraging this trend by collaborating with leading e-commerce platforms and enhancing their online stores. Due to their constant availability and worldwide accessibility, online retailers are surpassing conventional distribution methods in the topical pain relief sector.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America is the biggest segment with a market share of 35.0%, supported by various factors including a high rate of chronic pain disorders, a sophisticated healthcare system, and rising investments in research and development (R&D). The region's elderly population contributes to an increasing prevalence of issues such as musculoskeletal disorders and arthritis, enhancing the need for efficient pain management strategies. The extensive use of over-the-counter products, along with the presence of prescription-based alternatives, increases consumer access to topical pain relief choices. Moreover, positive reimbursement policies and robust backing from regulatory agencies foster innovation and the launch of new formulations. North America's proactive healthcare strategies, along with its emphasis on pain management education, position it as a leader in this sector, guaranteeing ongoing market growth and the uptake of innovative products. In 2024, Wellness Formulations, LLC introduced ralli(TM) Rapid Pain Relief, a groundbreaking topical analgesic sold at Walmart. With 10% menthol and natural components such as MSM, glucosamine, and Boswellia, it provides instant relief from muscle and joint discomfort. The product is available in gel, spray, and roll-on variations, enhancing both affordability and accessibility.

KEY REGIONAL TAKEAWAYS:

UNITED STATES TOPICAL PAIN RELIEF MARKET ANALYSIS

The market in the United States is growing with a market share of 91.50%, fueled by the growing incidence of chronic ailments and an escalating inclination towards non-invasive pain management options. Approximately 129 million individuals in the US experience at least one significant chronic illness, including heart disease, cancer, diabetes, obesity, or hypertension, according to the US Department of Health and Human Services. Such circumstances frequently result in ongoing discomfort, especially joint pain, muscle strain, and back pain, increasing the need for topical pain relievers. With increasing worries about opioids, people are looking for alternative pain relief methods, and topical solutions such as creams, gels, and patches provide effective pain control without the dangers linked to oral medications. Moreover, the older population, especially susceptible to ailments such as arthritis, is increasing the demand for specific, localized pain relief. Moreover, advancements in product compositions, like CBD-infused topical pain relievers, are also broadening user options, aiding the widespread acceptance of topical pain relief products.

EUROPE TOPICAL PAIN RELIEF MARKET ANALYSIS

Europe's topical pain relief market outlook is significantly influenced by the region's aging population and the growing prevalence of chronic pain conditions. As of January 1, 2023, the population of the European Union was 448.8 million, with more than one-fifth (21.3%) being 65 years or older, as reported by Eurostat. Elderly individuals are more vulnerable to ailments such as osteoarthritis, back discomfort, and joint pain, increasing the need for efficient pain relief options. With the growing interest in non-invasive therapies, more people are opting for topical analgesics like creams, gels, and patches, which provide focused relief with reduced side effects when compared to oral drugs. Moreover, the increase in health consciousness and the accessibility of over-the-counter items in drugstores and online retailers are also driving the market growth. Product formulation innovations, incorporating natural components such as CBD, are increasingly popular, drawing users who desire safer, more sustainable options. With the increasing need for localized pain relief, the European market for topical pain relief products is set for ongoing growth.

ASIA PACIFIC TOPICAL PAIN RELIEF MARKET ANALYSIS

In the Asia-Pacific (APAC) area, the rising incidence of musculoskeletal disorders and the heightened need for non-invasive pain management options are fueling the topical pain relief market. As reported by PubMed Central, a notable segment of older Asian communities experiences knee pain, with prevalence rates varying from 11% to 56% in China, 33% in Japan, 38% in Korea, and 61% in Vietnam. The increasing occurrence of joint pain, especially in older adults, is generating a significant need for efficient, localized pain relief solutions. Moreover, people are progressively choosing topical therapies because of their ease of use, reduced side effects, and availability. The growing healthcare infrastructure in developing regions such as India and Southeast Asia additionally supports market expansion, along with increased awareness of the advantages of topical analgesics compared to conventional oral medications.

LATIN AMERICA TOPICAL PAIN RELIEF MARKET ANALYSIS

In Latin America, the rising incidence of chronic illnesses are significantly propelling the market growth. As reported by PubMed Central, Brazil is believed to have approximately 928,000 fatalities each year as a result of chronic diseases. As a significant part of the population suffers from ailments such as arthritis, back pain, and joint problems, the need for effective pain relief options is increasing. Topical analgesics like creams and gels are becoming increasingly popular as non-invasive substitutes for oral medications. As individuals pursue more convenient and secure alternatives for pain relief, the market for topical analgesic products keeps growing. These factors contribute to topical pain relief market revenue in emerging markets.

MIDDLE EAST AND AFRICA TOPICAL PAIN RELIEF MARKET ANALYSIS

In the Middle East, chronic diseases are notably prevalent, especially in the UAE, where 23.0% of individuals report having chronic conditions like obesity, diabetes, and asthma/allergies, as noted by PubMed Central. The increasing prevalence of these chronic illnesses is driving the need for pain relief options, such as topical analgesics. As people seek non-invasive methods to alleviate pain from issues like joint discomfort and muscle strain, the market for topical pain relief solutions is set for expansion. This trend is enhanced by the growing awareness about the advantages of topical therapies compared to conventional oral medications in the area.

COMPETITIVE LANDSCAPE:

Major participants in the market are currently concentrating on product development, broadening their distribution channels, and improving marketing tactics to bolster their market presence. They are allocating resources towards research activities to develop innovative formulations, including quick-absorbing gels and durable patches, addressing various user requirements. Strategic collaborations with healthcare providers and retail channels are improving accessibility. Many are leveraging digital platforms to increase user engagement and awareness about their products. Sustainability initiatives, including eco-friendly packaging, are also gaining attention to align with individual preferences. Additionally, these companies are expanding their product portfolios to include natural and organic options, addressing the growing demand for safer and chemical-free alternatives. In August 2023, Johnson & Johnson introduced a new pain remedy, the topical Tylenol(R) Precise(TM) Pain Relieving Cream. Tylenol Precise accommodates active lifestyles with a fast-absorbing formula, odorless and fresh scent variants for subtle use, and a specially crafted rollerball for hands-free, clean application that keeps skin free from sticky residues.

The report provides a comprehensive analysis of the competitive landscape in the topical pain relief market with detailed profiles of all major companies, including:

  • Advacare Pharma
  • Exzell Pharma Inc.
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Topical Biomedics Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the topical pain relief market?

2. What is the future outlook of topical pain relief market?

3. What are the key factors driving the topical pain relief market?

4. Which region accounts for the largest topical pain relief market share?

5. Which are the leading companies in the global topical pain relief market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Topical Pain Relief Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapeutic Class

  • 6.1 Non-Opioids
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Opioids
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Formulation

  • 7.1 Cream
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gel
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Spray
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Patch
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Type

  • 8.1 Prescription Pain Relief
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Over the Counter (OTC) Pain Relief
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Pharmacy and Drug Stores
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Stores
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Stores
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Advacare Pharma
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Exzell Pharma Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Glaxosmithkline Plc
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Johnson & Johnson
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Novartis AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Pfizer Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Reckitt Benckiser Group Plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Sanofi S.A.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Sun Pharmaceutical Industries Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Topical Biomedics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Topical Pain Relief Market: Major Drivers and Challenges
  • Figure 2: Global: Topical Pain Relief Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Topical Pain Relief Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Topical Pain Relief Market: Breakup by Therapeutic Class (in %), 2025
  • Figure 5: Global: Topical Pain Relief Market: Breakup by Formulation (in %), 2025
  • Figure 6: Global: Topical Pain Relief Market: Breakup by Type (in %), 2025
  • Figure 7: Global: Topical Pain Relief Market: Breakup by Distribution Channel (in %), 2025
  • Figure 8: Global: Topical Pain Relief Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Topical Pain Relief (Non-Opioids) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Topical Pain Relief (Non-Opioids) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Topical Pain Relief (Opioids) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Topical Pain Relief (Opioids) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Topical Pain Relief (Cream) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Topical Pain Relief (Cream) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Topical Pain Relief (Gel) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Topical Pain Relief (Gel) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Topical Pain Relief (Spray) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Topical Pain Relief (Spray) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Topical Pain Relief (Patch) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Topical Pain Relief (Patch) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Topical Pain Relief (Other Formulations) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Topical Pain Relief (Other Formulations) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Topical Pain Relief (Prescription Pain Relief) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Topical Pain Relief (Prescription Pain Relief) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Topical Pain Relief (Over the Counter (OTC) Pain Relief) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Topical Pain Relief (Over the Counter (OTC) Pain Relief) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Topical Pain Relief (Pharmacy and Drug Stores) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Topical Pain Relief (Pharmacy and Drug Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Topical Pain Relief (Retail Stores) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Topical Pain Relief (Retail Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Topical Pain Relief (Online Stores) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Topical Pain Relief (Online Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: North America: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: North America: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: United States: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: United States: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Canada: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Canada: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Asia-Pacific: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Asia-Pacific: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: China: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: China: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Japan: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Japan: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: India: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: India: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: South Korea: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: South Korea: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Australia: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Australia: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Indonesia: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Indonesia: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Others: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Others: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Europe: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Europe: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Germany: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Germany: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: France: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: France: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: United Kingdom: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: United Kingdom: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Italy: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Italy: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Spain: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Spain: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Russia: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Russia: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Others: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Others: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Latin America: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Latin America: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Brazil: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Brazil: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Mexico: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Mexico: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Others: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Others: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Middle East and Africa: Topical Pain Relief Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Middle East and Africa: Topical Pain Relief Market: Breakup by Country (in %), 2025
  • Figure 81: Middle East and Africa: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Global: Topical Pain Relief Industry: SWOT Analysis
  • Figure 83: Global: Topical Pain Relief Industry: Value Chain Analysis
  • Figure 84: Global: Topical Pain Relief Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Topical Pain Relief Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Topical Pain Relief Market Forecast: Breakup by Therapeutic Class (in Million USD), 2026-2034
  • Table 3: Global: Topical Pain Relief Market Forecast: Breakup by Formulation (in Million USD), 2026-2034
  • Table 4: Global: Topical Pain Relief Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 5: Global: Topical Pain Relief Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 6: Global: Topical Pain Relief Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Topical Pain Relief Market: Competitive Structure
  • Table 8: Global: Topical Pain Relief Market: Key Players